Literatur
-
1
Enriquez-Sarano M, Tajik A J, Schaff H V, Orszulak T A, Bailey K R, Frye R L.
Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation.
Circulation.
1994;
90
830-837
-
2
Duarte I G, Murphy C O, Kosinski A S, Jones E L, Craver J M, Gott J P, Guyton R A.
Late survival after valve operation in patients with left ventricular dysfunction.
Ann Thorac Surg.
1997;
64
1089-1095
-
3
Schlant R C.
Timing of surgery for patients with nonischemic severe mitral regurgitation.
Circulation.
1999;
99
338-339
-
4
Bolling S F, Deeb G M, Brunsting L A, Bach D S.
Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy.
J Thorac Cardiovasc Surg.
1995;
109
676-683
-
5
Bach D S, Bolling S F.
Improvement following correction of secondary mitral insufficiency in end-stage cardiomyopathy with mitral annuloplasty.
Am J Cardiol.
1996;
78
966-969
-
6
Bishay E S, McCarthy P M, Cosgrove D M, Hoercher K J, Smedira N G, Mukherjee D, White J, Blackstone E H.
Mitral valve surgery in patients with severe left ventricular dysfunction.
Eur J Cardiothorac Surg.
2000;
17
213-221
-
7
Haan C K, Cabral C I, Conetta D A, Coombs L P, Edwards F H.
Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery.
Ann Thorac Surg.
2004;
78
820-825
-
8
Starling M R, Kirsch M, Montgomery D G.
Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction.
Am J Coll Cardiol.
1993;
22
239-248
-
9
Conway M, Bottomley P, Ouwerkerk R.
Mitral regurgitation ; impaired systolic function, excentric hypertrophy, and increased severity are linked to lower phophocreatinine/ATP ratios in humans.
Circulation.
1998;
97
1716-1723
-
10
Starling M R, Supiano M A, Petrusha J A.
Relationship of left ventricular contractility to sympathetic nervous system activation and β-adrenergic receptor desensitization (abstract).
Circulation.
1997;
96
469
-
11
Bozkurt B, Kribbs S B, Clubb F J.
Pathophysiologically relevant concentrations of tumor necrosis factor α promote progressive left ventricular dysfunction and remodelling in rats.
Circulation.
1998;
97
1382-1391
-
12
Leung D Y, Armstrong G, Griffin B P, Thomas J D, Marwick T H.
Latent left ventricular dysfunction in patients with mitral regurgitation: Feasability of measuring diminished contractile reserve from a simplified model of noninvasively derived left ventricular pressure-volume loops.
Am Heart J.
1999;
137
427-434
-
13
Flemming M A, Oral H, Rothman E D, Briesmiester K, Petrusha J, Starling M R.
Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation.
Am Heart J.
2000;
140
476-482
-
14
Wu A H, Aaronson K D, Bolling S F, Pagani F D, Welch K, Koelling T M.
Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.
J Am Coll Cardiol.
2005;
45
381-387
-
15
Ofili E, Oduwole A, Lapa-Bula R.
Surgical timing for mitral valve regurgitation.
Echocardiography.
2000;
17
285-292
-
16
Ling L H, Enriquez-Sarano M, Seward J B.
Clinicl outcome of mitral regurgitation due to flail leaflet.
N Engl J Med.
1996;
335
1417-1423
-
17
Enriquez-Sarano M, Avierinos J F, Messika-Zeitoun D.
Quantitative determinants of the outcome of asymptomatic mitral regurgitation.
N Engl J Med.
2005;
352
875-885
-
18
Rosenhek R, Rader F, Klaar U.
Outcome of watchful waiting in asymptomatic severe mitral regurgitation.
Circulation.
2006;
113
2238-2244
-
19
Enriquez-Sarano M.
Timing of mitral valve surgery.
Heart.
2002;
87
79-85
-
20
Rostagno C, Caciolli S, Fradella G F, Stefano P L.
Early effects of mitral valve repair in patients with left ventricular dysfuntion: an echocardiographic study.
European Journal of Heart Failure.
2007;
Suppl 1
26
-
21
Bolling S F, Pagani F D, Deeb G M, Bach D S.
Intermediate-term outcome of mitral reconstruction in cardiomyopathy.
J Thorac Cardiovasc Surg.
1998;
115
381-388
-
22
Badhwar V, Bolling S F.
Mitral valve surgery in the patients with left ventricular dysfunction.
Semin Thorac Cardiovasc Surg.
2002;
14
133-136
-
23
Hendren W G, Memec J J, Lytle B W, Loop F D, Taylor P C, Stewart R W, Cosgrove D M.
Mitral valve repair for ischemic mitral insufficiency.
Ann Thorac Surg.
1991;
52
1246-1252
-
24
David T E, Uden D E, Strauss H D.
The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation.
Circulation.
1983;
68 (Suppl II)
II76-II82
-
25
Lee E M, Shapiro L M, Wells F C.
Importance of subvalvular preservation and early operation in mitral valve surgery.
Circulation.
1996;
94
2117-2123
-
26
Goldman M E, Mora F, Guarino T, Fuster V, Mindich B P.
Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiographic study.
J Am Coll Cardiol.
1987;
10
568-575
-
27
Tribouilloy C M, Enriquez-Sarano M, Schaff H V, Orszulak T A, Bailey K R, Tajik A J, Freye R L.
Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rational for optimising surgical indications.
Circulation.
1999;
26
400-405
-
28
Bonow R O, Carabello B, Chatterjee K, deLeon Jr A C, Faxon D P.
Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS.
ACC /AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology / American Heart Association Task Force on practice guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Valvular Heart Disease) J Am Coll Cardiol.
2006;
48
e1-148
Dr. Thomas Günther
Klinik für Herz- und Gefäßchirurgie
Deutsches Herzzentrum
Lazarettstr. 36
80636 München
Phone: 089 1218-4111
Fax: 089 1218-4123
Email: Guenther@dhm.mhn.de
